Compound index

Why people use hCG for fertility or alongside TRT, how the goals differ, and source-specific IU doses, timing, side effects and storage.

Estimated concentration · study setup and sources inside

HGH is used medically to replace a diagnosed growth-hormone deficiency. Physique users seek fat loss, recovery and muscle fullness, but those goals differ from replacement treatment; swelling, hand symptoms and impaired glucose control can offset the hoped-for benefits.

Estimated concentration · study setup and sources inside

Semaglutide can reduce hunger and food intake, helping people lose weight. Wegovy injections are prescribed for weight management; Ozempic injections treat type 2 diabetes. Both are taken weekly, with gradual dose increases to help manage digestive side effects.

Published reference · fixed study profile

Oral semaglutide offers a daily tablet option for adults with type 2 diabetes who want to avoid injections. The morning routine matters: food, drink and other tablets affect absorption, and different semaglutide products cannot be compared milligram for milligram.

Published reference · fixed study profile

Tirzepatide can reduce appetite and food intake, helping people lose weight and improve blood-sugar control. In the US, Zepbound is the weight-management brand and Mounjaro treats type 2 diabetes. Both are weekly injections; digestive side effects and the right dose for the treatment goal are the main practical trade-offs.

Published reference · fixed study profile

Retatrutide is an experimental weekly injection attracting interest for substantial weight loss and appetite-related effects. It adds a third hormone pathway to the approach used by tirzepatide. Large trials have reported results, but retatrutide remains unapproved and has no approved prescribing dose.

Estimated concentration · study setup and sources inside

Mazdutide is a weekly weight-management drug that also has a type 2 diabetes indication in China. People comparing it with tirzepatide want to know about appetite, weight loss and tolerability; it targets a different combination of hormone receptors, so doses are not interchangeable.

Estimated concentration · study setup and sources inside

Cagrilintide explained: appetite, trial doses, nausea and the difference between standalone use and CagriSema.

Estimated concentration · study setup and sources inside

Trulicity doses, weekly timing, weight-loss expectations and side effects in plain language.

Estimated concentration · study setup and sources inside

Symlin explained: meal-time doses, fullness, insulin coordination and low-blood-sugar risk.

Estimated concentration · study setup and sources inside

Survodutide for weight and liver fat: research doses, treatment duration and practical differences from other incretin drugs.

Estimated concentration · study setup and sources inside

5-Amino-1MQ for fat loss: capsule-dose claims, animal findings and what remains unknown for people.

Relative timing · not a blood concentration

Adipotide fat-loss claims, kidney concerns and why animal results do not establish a human cycle.

Relative timing · not a blood concentration

HGH Fragment 176–191 and AOD-9604: fat-loss expectations, reported amounts and the product-name confusion.

Relative timing · not a blood concentration

MGF for muscle recovery and growth: reported dose claims, workout timing and the difference from PEG-MGF.

Relative timing · not a blood concentration

PEG-MGF versus MGF: muscle-growth claims, reported schedules and the limits of the longer-lasting promise.

Relative timing · not a blood concentration

IGF-1 DES: workout and local-growth claims, reported amounts and how it differs from LR3.

Relative timing · not a blood concentration

IGF-1 LR3 for muscle growth: reported doses and cycles, DES comparison and glucose-related concerns.

Relative timing · not a blood concentration

CJC-1295 with DAC appeals to people seeking longer-lasting GH stimulation with fewer injections. Compare reported weekly use, trial doses, recovery goals and the trade-offs.

Relative timing · not a blood concentration

CJC-1295 no DAC is sought for better sleep, workout recovery and a leaner physique, often with ipamorelin. Compare reported doses, duration and the daily-use trade-off.

Relative timing · not a blood concentration

Ipamorelin for sleep, workout recovery and body-composition goals: reported dose examples, what people notice, side effects and how it differs from CJC-1295.

Relative timing · not a blood concentration

Sermorelin for sleep and recovery: reported clinic doses, treatment time and differences from HGH.

Relative timing · not a blood concentration

Tesamorelin for visceral belly fat: Egrifta doses, how long treatment is studied and what happens after stopping.

Relative timing · not a blood concentration

GHRP-2: recovery and appetite expectations, reported doses and the difference between a GH pulse and a lasting result.

Relative timing · not a blood concentration

GHRP-6 for hunger and recovery: published dose context, common comparisons and what increased appetite does not prove.

Relative timing · not a blood concentration

MK-677 explained: appetite, sleep and muscle expectations, research doses and water-weight trade-offs.

Relative timing · not a blood concentration

ACE-031 muscle-growth research: trial doses, myostatin claims and why bigger muscle measures are not enough.

Relative timing · not a blood concentration

AICAR for endurance: where the exercise-pill claim comes from, reported amounts and comparison with Cardarine.

Relative timing · not a blood concentration

EPO explained: anemia treatment, endurance claims, label-dose context and why blood counts need medical monitoring.

Relative timing · not a blood concentration

HMG versus hCG for fertility: Menopur dose context, months-long treatment and why testosterone levels do not show sperm count.

Relative timing · not a blood concentration

Gonadorelin versus hCG on TRT: reported clinic doses, fertility expectations and why pump timing matters.

Relative timing · not a blood concentration

Kisspeptin for libido and fertility: research versus reported doses, KP10/KP54 differences and realistic expectations.

Relative timing · not a blood concentration

Why people consider BPC-157 for tendon, ligament, muscle and gut recovery, plus oral versus injected forms, expected timing and practical trade-offs.

Relative timing · not a blood concentration

Why people research TB-500 for tendon, muscle and joint recovery, how reported courses are described, and what to know when comparing it with BPC-157.

Relative timing · not a blood concentration

The TB-500 fragment is a small piece of thymosin beta-4. Researchers study both the fragment and what it breaks down into; these can have different effects in laboratory experiments.

Relative timing · not a blood concentration

Thymosin Alpha-1: immune-support claims, Zadaxin doses and why the illness being treated matters.

Relative timing · not a blood concentration

ARA-290 for nerve symptoms: research doses, 28-day studies and realistic expectations for neuropathy.

Relative timing · not a blood concentration

SS-31 / elamipretide: energy claims, Forzinity doses, Barth syndrome approval and what fatigue studies found.

Published reference · fixed study profile

MOTS-c for energy, endurance and metabolic goals: reported amounts, realistic expectations and the difference between exercise research and peptide injections.

Relative timing · not a blood concentration

LL-37 for immune, gut and wound-healing questions: what people seek, reported injection amounts and what topical human trials actually found.

Relative timing · not a blood concentration

KPV for gut and skin concerns: oral versus injected products, reported dose context and realistic expectations for inflammation claims.

Relative timing · not a blood concentration

Thymalin for immune support and healthy-aging questions: the reported short course, product differences and what the clinical study can tell you.

Relative timing · not a blood concentration

VIP nasal spray and peptide uses: CIRS questions, published dose context and how nasal, inhaled and injected formulations differ.

Relative timing · not a blood concentration

Dermorphin and pain relief: why it attracts interest, why opioid potency is not a recovery benefit, and the serious breathing risk.

Relative timing · not a blood concentration

PNC-27 is a research peptide designed to damage cancer-cell membranes. Laboratory studies examine this idea; they do not establish a cancer treatment for people.

Relative timing · not a blood concentration

FOXO4-DRI is a research peptide designed to help remove senescent cells: damaged cells that remain alive after they stop dividing. Cell and mouse studies do not yet establish rejuvenation in people.

Relative timing · not a blood concentration

GHK-Cu for skin and hair: realistic cosmetic goals, topical versus injection evidence, and separately sourced amounts, frequency and duration.

Relative timing · not a blood concentration

AHK-Cu for fuller-looking hair: topical product context, comparison with GHK-Cu and what the follicle study can—and cannot—show.

Relative timing · not a blood concentration

Glutathione for skin and antioxidant goals: oral study doses, injection trade-offs and why a higher blood level is not a guaranteed detox or cosmetic result.

Relative timing · not a blood concentration

Semax for focus and mental fatigue: nasal-drop examples, concentration differences and realistic expectations for everyday nootropic use.

Relative timing · not a blood concentration

Selank for anxiety and calm focus: nasal-drop context, comparison with Semax and what to expect from the limited human research.

Relative timing · not a blood concentration

Adamax versus Semax: focus and motivation claims, a named reported-dose example and the uncertainty behind “stronger” nootropic marketing.

Relative timing · not a blood concentration

Cerebrolysin for cognition and recovery questions: clinical dose context, why milliliters matter and how nootropic goals differ from stroke research.

Relative timing · not a blood concentration

Pinealon for memory and brain-aging questions: capsule versus injection amounts, realistic expectations and what its research actually measures.

Relative timing · not a blood concentration

PE-22-28 is an experimental peptide that blocks TREK-1, a channel involved in nerve-cell electrical activity. Mouse studies found antidepressant-like responses, but human depression relief has not been demonstrated.

Relative timing · not a blood concentration

DSIP for sleep: falling asleep versus staying asleep, the mixed human evidence and why a wearable deep-sleep score is not the whole outcome.

Relative timing · not a blood concentration

Epithalon for sleep and longevity: reported dose ranges, Epithalamin confusion and why telomere changes do not prove longer life.

Relative timing · not a blood concentration

N-Acetyl Epitalon Amidate versus regular Epitalon: sleep and longevity claims, reported-use context and whether a modified form is actually better.

Relative timing · not a blood concentration

Cartalax for joint comfort and cartilage questions: reported amounts, realistic recovery expectations and why less pain does not prove cartilage regrowth.

Relative timing · not a blood concentration

Chonluten is a short peptide often linked to lung-health research. A direct study found changes in inflammatory signals in laboratory immune cells; it did not test breathing or lung recovery in people.

Relative timing · not a blood concentration

Cortagen for nerve recovery and cognition: the preclinical signal, dosing uncertainty and the difference between a nerve experiment and everyday brain fog.

Relative timing · not a blood concentration

Livagen is a short peptide studied in liver tissue and isolated blood cells. The research describes changes in cell growth and DNA packaging, not a proven liver-detox or liver-repair treatment in people.

Relative timing · not a blood concentration

Ovagen for liver and digestive-health questions: capsule directions, comparison with Livagen and limits of detox and liver-repair claims.

Relative timing · not a blood concentration

Prostamax for urinary and prostate concerns: a reported-dose example, name confusion and what the preclinical research says about everyday symptoms.

Relative timing · not a blood concentration

Testagen for testosterone and vitality questions: reported amounts, libido versus blood tests and why the peptide is not established TRT or fertility treatment.

Relative timing · not a blood concentration

Vesugen for circulation and vascular-aging questions: capsule-course context, what cell research shows and why “vessel support” is not plaque removal.

Relative timing · not a blood concentration

People look at Vilon for immune support and healthy aging. Its cell research is interesting, but it does not show that a course prevents infections or makes people live longer. Online dose suggestions also vary substantially.

Relative timing · not a blood concentration

Melanotan I attracts people who want a darker tan. Its medicine form, afamelanotide, is used for a rare light-sensitivity disorder; the approved implant is very different from tanning powders sold online. A tan does not replace sun protection.

Relative timing · not a blood concentration

Melanotan II is sought for a darker tan and sometimes for sexual effects. Small human studies observed both, alongside nausea and unwanted erections. The practical trade-off is that visible pigmentation does not establish a safe tanning routine or protection from UV damage.

Relative timing · not a blood concentration

PT-141 is researched for low sexual desire. As VYLEESI, bremelanotide is an on-demand treatment for acquired, generalized low desire causing distress in premenopausal women. It is not a general performance enhancer, and nausea is a common trade-off.

Published reference · fixed study profile

Oxytocin gets attention as a “bonding hormone” and possible libido aid. A nasal-spray trial in women did not outperform placebo for sexual dysfunction. Its established medical use is different: supervised labor and postpartum care.

Relative timing · not a blood concentration

Alprostadil is an erection treatment that acts locally to increase blood flow. It can be useful when a clinician chooses injection therapy, but finding the right dose and learning the technique matter: pain and prolonged erections are important trade-offs.

Relative timing · not a blood concentration

Injectable L-carnitine is discussed for fat loss, workout pumps and performance. It helps the body handle fatty acids, but that role does not mean an injection automatically burns body fat. The approved IV medicine treats specific deficiency situations; bodybuilding use is a different context.

Relative timing · not a blood concentration

NAD+ infusions are marketed for energy, clearer thinking and healthy aging. Human studies have measured changes in NAD-related blood markers, but that is not the same as proving a lasting improvement in energy or reversing aging. Time, cost and infusion tolerability are practical considerations.

Relative timing · not a blood concentration

SLU-PP-332 draws interest for fat loss and endurance—the “exercise mimetic” idea. Mouse studies showed exercise-like metabolic changes, but they do not show that it replaces training or produces the same results in people. Human online experiments remain uncontrolled reports.

Relative timing · not a blood concentration

Bacteriostatic water is a preserved pharmaceutical diluent used to dissolve or dilute compatible medicines. Its preservative does not sterilize a powder or give every mixed peptide a 28-day shelf life.

Informational · not plottable

“AA water” usually means water containing acetic acid, used in some laboratory peptide-solubility work. The name alone does not establish acid concentration, sterility, preservative content or suitability for injection.

Informational · not plottable

Vitamin B12 can make a real difference when tiredness or nerve problems come from deficiency. Extra B12 is not an established energy boost when levels are already adequate. The useful choice is how to correct the cause of low B12—not simply whether a shot sounds stronger.

Informational · not plottable

Vitamin D3 is useful for meeting vitamin D needs and correcting deficiency, especially for bone health. Taking more is not automatically better: high-dose wellness claims should be separated from ordinary intake and clinician-directed deficiency treatment.

Informational · not plottable

Melatonin is used to help with sleep timing and some sleep problems. It is not simply a stronger-is-better sedative: when it is taken and whether it releases quickly or slowly can matter as much as the amount.

Informational · not plottable

Botulinum toxin is used to soften expression lines and, in different treatment plans, manage conditions such as migraine or muscle overactivity. Cosmetic results come from relaxing selected muscles. The product, treatment area and injector’s assessment matter more than a generic “Botox dose”.

Informational · not plottable

Lemon Bottle is advertised for reducing small areas of fat, such as under the chin. The central problem is product identity: its distributor told Swissmedic that the original ampoule is an external-use cosmetic, not an injection or lipolysis product.

Informational · not plottable

LC120 is a four-ingredient “lipotropic” shot marketed for weight-management support. Its name is not a standard recipe: listings disagree about whether the ingredient amounts refer to 1 mL or the whole 10 mL vial. That difference matters before comparing doses.

Informational · not plottable

LC216, also called Lipo-B or Lipo-C with B12, combines carnitine, arginine, methionine, inositol and choline (MIC) and B vitamins. One published product report specifies 216 mg of listed ingredients per 10 mL serving—not per mL.

Informational · not plottable

LC425 FOCUS is marketed for energy, mental sharpness and weight-management support. It adds ATP and an ingredient called “Eria Jarensis” to a carnitine/MIC base. That makes it different from a plain vitamin shot, but the name does not prove better focus or fat loss.

Informational · not plottable

Lipo-C Fat Blaster: what to expect for weight loss and energy, how LC526 differs from GLP-1 medicines, and how to read its ingredients, mg/mL and syringe units.

Informational · not plottable

SUPER SHRED is a marketed nutrient-and-drug blend. QSC’s LC553 declaration includes albuterol alongside carnitine, MIC (methionine, inositol and choline), ATP and B12; albuterol makes this materially different from a vitamin-only shot.

Informational · not plottable

SHRED is a marketed blend of carnitine, methionine, inositol and choline (MIC) and B vitamins. Beautide lists a 350.25 mg/mL example; its panel does not list the albuterol or ATP found in the cited SUPER SHRED product.

Informational · not plottable

Lipo-Mino-Mix is marketed for energy and weight-management support, often alongside a broader plan. It combines MIC nutrients and B vitamins, but the recipe varies: Olympia adds carnitine only to Mix-C, while Legere’s panel includes B12. Check the version before comparing shots.

Informational · not plottable

SUPER Human Blend is a commercial amino-acid and nutrient mixture, not a single peptide. Identifiable examples differ: PrymaLab declares eight components per dry vial, while Patriot lists nine components, including NAC, with amounts per mL.

Informational · not plottable

Healthy Hair, Skin & Nails is a commercial B-vitamin and nutrient blend name. BlueNex’s example lists nine components per 10 mL, including biotin; that declaration does not demonstrate better hair growth or skin quality.

Informational · not plottable

GGH is a marketed mixture of GHK-Cu, glutathione, histidine, glycine and NADH. A named seller provides component amounts, but its heading conflicts with their sum—an important distinction before treating the product name as a known strength.

Informational · not plottable

Relaxation PM is a marketed sleep blend. Gold Standard Tides declares GABA, melatonin, arginine and glutamine at a combined 226 mg/mL; it is a research-supplier product, not the same formulation as an approved oral melatonin medicine.

Informational · not plottable